Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Research Data
Search by expertise, name or affiliation
Interpreting coagulation assays
David Green
*
*
Corresponding author for this work
Medicine, Hematology Oncology Division
Research output
:
Contribution to journal
›
Review article
›
peer-review
18
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Interpreting coagulation assays'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Heparin
100%
Thrombosis
100%
Blood Clotting Factor
100%
Prothrombin Time
100%
Partial Thromboplastin Time
100%
Recurrent Disease
50%
Warfarin
50%
Hemostat
50%
Liver Disease
50%
Coagulopathy
50%
Disseminated Intravascular Coagulation
50%
Prothrombin
50%
Anticoagulant Therapy
50%
D-Dimer
50%
Haemophilia A
50%
Lupus Anticoagulant
50%
Blood Clotting Inhibitor
50%
Consultation
50%
Keyphrases
Coagulation Assays
100%
Heparin
66%
Prothrombin Time
66%
Activated Partial Thromboplastin Time (aPTT)
66%
Clot
33%
Liver Disease
33%
Thrombotic
33%
Clinical Situation
33%
Hemophilia
33%
Anticoagulants
33%
Thrombosis Risk
33%
Anticoagulant Therapy
33%
D-dimer
33%
Expert Consultation
33%
Coagulopathy
33%
Warfarin
33%
Clotting Factor Deficiency
33%
Disseminated Intravascular Coagulation
33%
Prothrombin
33%
Lupus Anticoagulant
33%
Clotting Factors
33%
Hemostatic Factors
33%
Bethesda Assay
33%
Thrombosis Recurrence
33%
Mixing Test
33%
Lupus Antibodies
33%
FVIII Inhibitors
33%
Pharmacology, Toxicology and Pharmaceutical Science
Prothrombin
100%
Blood Clotting Factor
66%
Heparin
66%
Thrombosis
66%
Thromboplastin
66%
Liver Disease
33%
Recurrent Disease
33%
Anticoagulant Agent
33%
D Dimer
33%
Hemostatic Agent
33%
Blood Clotting Disorder
33%
Disseminated Intravascular Clotting
33%
Blood Clotting Inhibitor
33%
Warfarin
33%
Haemophilia A
33%
Lupus Anticoagulant
33%